{
  "_id": "fb228494cf27554872d2fff73a47794b4120382306f64746e7931f2c074cd5ba",
  "feed": "wall-street-journal",
  "title": "World-Wide",
  "text": "<p>---</p><p>Iranian and U.S. officials are entering a crucial week of talks to restore the 2015 nuclear deal, with significant differences remaining on several key issues.</p><p>---</p><p>A case over federal authority to limit greenhouse-gas emissions drew out sharply different principles during arguments at the Supreme Court.</p><p>---</p><p>Climate experts called an assessment of the impacts of climate change the direst ever offered by the IPCC, a panel of scientists convened by the U.N.</p><p>---</p><p>The Taliban said Afghans will no longer be allowed to leave the country without a good reason, and women will be barred from traveling without a chaperone, rejecting a key U.S. demand.</p><p>---</p><p>The FDA approved a new customized, cell-based treatment for blood cancer from J&amp;J that is the first such therapy in the U.S. to be developed initially in China.</p><p>License this article from Dow Jones Reprint Service</p>",
  "published": "2022-03-01T00:00:00.000Z",
  "tags": [
    {
      "id": "US4781601046",
      "name": "Johnson & Johnson",
      "offsets": [
        {
          "start": 734,
          "end": 737
        }
      ],
      "nexusId": "10010560"
    }
  ]
}